by admin | Nov 22, 2022 | Media
RxCelerate acquires Methuselah Health and launches ProQuant™ world-beating proteomics service Cambridge, UK and Cambridge, MA Tuesday 22nd November 2022, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today announced...
by admin | Jul 19, 2022 | Media
RxCelerate launch RxNfinity™: a next-generation machine learning-enabled small molecule discovery platform Cambridge, UK and Cambridge, MA – Tuesday 19th July 2022, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today...
by admin | Feb 16, 2021 | Media
RxCelerate launch Galaxy™: a next-generation antibody discovery platform Cambridge, UK and Cambridge, MA – Tuesday 16th February 2021, 1pm GMT RxCelerate, a leading international out-sourced drug discovery and development platform, today revealed details of a new...
by admin | Jan 20, 2020 | Media
RxCelerate expands space to 25,000 square feet Cambridge, UK – January 23, 2020 BioMed Realty (“BioMed Realty” or the “Company”), a Blackstone portfolio company and a leading provider of real estate solutions to the life sciences community, and RxCelerate, one of the...
by admin | Feb 5, 2019 | Media
RxCelerate acquires cutting-edge molecular modelling company Prosarix RxCelerate, one of the leading out-sourced drug discovery and development platforms in the United Kingdom, announced today that it has acquired UK-based molecular modelling company...
